National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2013 (No. 6) (No. PB 29 of 2013) (Cth)
PB 29 of 2013
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2013
(No. 6)1
National Health Act 1953
I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this Instrument under sections 84AF, 84AK, 85, 85A, 88 and 101 of the National Health Act 1953.
Dated 21 May 2013
FELICITY McNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health and Ageing
1 Name of Instrument
(1) This Instrument is the National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2013 (No. 6).
(2) This Instrument may also be cited as PB 29 of 2013.
2 Commencement
This Instrument commences on 1 June 2013.
3 Amendment of National Health (Listing of Pharmaceutical Benefits) Instrument 2012 (PB 71 of 2012)
Schedule 1 amends the National Health (Listing of Pharmaceutical Benefits) Instrument 2012 (PB 71 of 2012).
Schedule 1 Amendments
Schedule 1, entry for Ampicillin in each of the forms: Powder for injection 500 mg (as sodium); and Powder for injection 1 g (as sodium)
omit from the column headed “Responsible Person” for the brand “Ibimycin” (all instances): TS substitute: WQ
Schedule 1, entry for Carboplatin in each of the forms: Solution for I.V. injection 50 mg in 5 mL; Solution for I.V. injection 150 mg in 15 mL; and Solution for I.V. injection 450 mg in 45 mL
insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:
| Carbaccord | WQ | MP | See Note 3 | See Note 3 | 1 | D(100) |
Schedule 1, entry for Ciprofloxacin in the form Tablet 250 mg (as hydrochloride)
omit:
| Profloxin | HX | MP NP | C1143 C1431 C1432 C1572 C1573 | 14 | 0 | 14 |
Schedule 1, entry for Citalopram in the form Tablet 10 mg (as hydrobromide)
insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:
| Citalopram-GA | GN | MP NP | C1211 | 28 | 5 | 28 |
Schedule 1, entry for Citalopram in the form Tablet 40 mg (as hydrobromide)
insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:
| Citalopram-GA | GN | MP NP | C1211 | 28 | 5 | 28 |
Schedule 1, entry for Epoetin Beta
omit:
| Injection 20,000 units in 0.6 mL pre-filled syringe | Injection | NeoRecormon | RO | MP See Note 1 | C1957 C3334 | 12 | 5 | 6 | D(100) |
Schedule 1, entry for Famciclovir in the form Tablet 500 mg [Maximum Quantity 56; Number of Repeats 5]
insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:
| Auro-Famciclovir 500 | DO | MP NP | C3626 C3627 C3628 C3629 | P3626 P3627 P3628 P3629 | 56 | 5 | 56 |
Schedule 1, entry for Felodipine in the form Tablet 2.5 mg (extended release)
omit from the column headed “Responsible Person” for the brand “Felodur ER 2.5 mg”: AL substitute: ZA
Schedule 1, entry for Felodipine in the form Tablet 5 mg (extended release)
omit from the column headed “Responsible Person” for the brand “Felodur ER 5 mg”: AL substitute: ZA
Schedule 1, entry for Felodipine in the form Tablet 10 mg (extended release)
omit from the column headed “Responsible Person” for the brand “Felodur ER 10 mg”: AL substitute: ZA
Schedule 1, entry for Flucloxacillin in each of the forms: Powder for injection 500 mg (as sodium); and Powder for injection 1 g
(as sodium)
omit from the column headed “Responsible Person” for the brand “Flubiclox” (all instances): TS substitute: WQ
Schedule 1, entry for Gabapentin in the form Tablet 600 mg
insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:
| Gabapentin Aspen 600 | FM | MP NP | C2664 | 100 | 5 | 100 |
Schedule 1, entry for Gabapentin in the form Tablet 800 mg
insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:
| Gabapentin Aspen 800 | FM | MP NP | C2664 | 100 | 5 | 100 |
Schedule 1, entry for Gemcitabine in the form Powder for I.V. infusion 200 mg (as hydrochloride)
omit from the column headed “Responsible Person” for the brand “Gemcitabine Actavis”: TA substitute: WQ
Schedule 1, entry for Gemcitabine in the form Powder for I.V. infusion 1 g (as hydrochloride)
omit from the column headed “Responsible Person” for the brand “Gemcitabine Actavis”: TA substitute: WQ
Schedule 1, entry for Gemcitabine in the form Powder for I.V. infusion 2 g (as hydrochloride)
insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:
| Gemcitabine Actavis 2000 | WQ | MP | See Note 3 | See Note 3 | 1 | D(100) |
Schedule 1, entry for Glucose Indicator―Blood
omit:
| Test strips, 50 (TRUEbalance) | For external use | TRUEbalance | NX | MP NP | 2 | 5 | 1 |
| MP | P3035 | 2 | 11 | 1 | |||
| Test strips, 50 (TRUEresult) | For external use | TRUEresult | NX | MP NP | 2 | 5 | 1 |
| MP | P3035 | 2 | 11 | 1 | |||
| Test strips, 50 (TrueTrack) | For external use | TrueTrack | NX | MP NP | 2 | 5 | 1 |
| MP | P3035 | 2 | 11 | 1 |
Schedule 1, after entry for Glucose Indicator―Blood in the form Test strips, 100 (FreeStyle Optium)
insert in the columns in the order indicated:
| Test strips, 100 (TRUEbalance) | For external use | TRUEbalance | NX | MP NP | 1 | 5 | 1 |
| MP | P3035 | 1 | 11 | 1 | |||
| Test strips, 100 (TRUEresult) | For external use | TRUEresult | NX | MP NP | 1 | 5 | 1 |
| MP | P3035 | 1 | 11 | 1 | |||
| Test strips, 100 (TRUEtrack) | For external use | TRUEtrack | NX | MP NP | 1 | 5 | 1 |
| MP | P3035 | 1 | 11 | 1 |
Schedule 1, entry for Lansoprazole
omit:
| Lansoprazole | Tablet 30 mg (orally disintegrating) | Oral | Zoton FasTabs | PF | MP NP | C1177 C1337 C1533 | P1177 | 28 | 1 | 28 |
| MP NP | C1177 C1337 C1533 | P1337 P1533 | 28 | 5 | 28 |
substitute:
| Lansoprazole | Tablet 30 mg (orally disintegrating) | Oral | Zopral ODT | AF | MP NP | C1177 C1337 C1533 | P1177 | 28 | 1 | 28 |
| Zoton FasTabs | PF | MP NP | C1177 C1337 C1533 | P1177 | 28 | 1 | 28 | |||
| Zopral ODT | AF | MP NP | C1177 C1337 C1533 | P1337 P1533 | 28 | 5 | 28 | |||
| Zoton FasTabs | PF | MP NP | C1177 C1337 C1533 | P1337 P1533 | 28 | 5 | 28 |
Schedule 1, entry for Lansoprazole in the form Tablet 15 mg (orally disintegrating)
insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:
| Zopral ODT | AF | MP NP | C1337 C1533 | 28 | 5 | 28 |
Schedule 1, entry for Naltrexone
omit from the column headed “Brand”: Naltrexone generichealth substitute: Naltrexone GH
Schedule 1, entry for Rosuvastatin
substitute:
| Rosuvastatin | Tablet 5 mg (as calcium) | Oral | APO-Rosuvastatin | TX | MP | C4225 C4228 | P4228 | 30 | 5 | 30 |
| NP | C4228 | 30 | 5 | 30 | ||||||
| Cavstat | AF | MP | C1540 C3047 C4225 C4228 | P1540 P4228 | 30 | 5 | 30 | |||
| NP | C1540 C4228 | 30 | 5 | 30 | ||||||
| Chem mart Rosuvastatin | CH | MP | C4225 C4228 | P4228 | 30 | 5 | 30 | |||
| NP | C4228 | 30 | 5 | 30 | ||||||
| Crestor | AP | MP | C1540 C3047 C4225 C4228 | P1540 P4228 | 30 | 5 | 30 | |||
| NP | C1540 C4228 | 30 | 5 | 30 | ||||||
| Rosuvastatin Actavis 5 | WQ | MP | C1540 C3047 C4225 C4228 | P1540 P4228 | 30 | 5 | 30 | |||
| NP | C1540 C4228 | 30 | 5 | 30 | ||||||
| Rosuvastatin GH | GQ | MP | C1540 C3047 C4225 C4228 | P1540 P4228 | 30 | 5 | 30 | |||
| NP | C1540 C4228 | 30 | 5 | 30 | ||||||
| Rosuvastatin RBX | RA | MP | C4225 C4228 | P4228 | 30 | 5 | 30 | |||
| NP | C4228 | 30 | 5 | 30 | ||||||
| Rosuvastatin Sandoz | SZ | MP | C4225 C4228 | P4228 | 30 | 5 | 30 | |||
| NP | C4228 | 30 | 5 | 30 | ||||||
| Terry White Chemists Rosuvastatin | TW | MP | C4225 C4228 | P4228 | 30 | 5 | 30 | |||
| NP | C4228 | 30 | 5 | 30 | ||||||
| APO-Rosuvastatin | TX | MP | C4225 C4228 | P4225 | 30 | 11 | 30 | |||
| Cavstat | AF | MP | C1540 C3047 C4225 C4228 | P3047 P4225 | 30 | 11 | 30 | |||
| Chem mart Rosuvastatin | CH | MP | C4225 C4228 | P4225 | 30 | 11 | 30 | |||
| Crestor | AP | MP | C1540 C3047 C4225 C4228 | P3047 P4225 | 30 | 11 | 30 | |||
| Rosuvastatin Actavis 5 | WQ | MP | C1540 C3047 C4225 C4228 | P3047 P4225 | 30 | 11 | 30 | |||
| Rosuvastatin GH | GQ | MP | C1540 C3047 C4225 C4228 | P3047 P4225 | 30 | 11 | 30 | |||
| Rosuvastatin RBX | RA | MP | C4225 C4228 | P4225 | 30 | 11 | 30 | |||
| Rosuvastatin Sandoz | SZ | MP | C4225 C4228 | P4225 | 30 | 11 | 30 | |||
| Terry White Chemists Rosuvastatin | TW | MP | C4225 C4228 | P4225 | 30 | 11 | 30 | |||
| Tablet 10 mg (as calcium) | Oral | APO-Rosuvastatin | TX | MP | C4225 C4228 | P4228 | 30 | 5 | 30 | |
| NP | C4228 | 30 | 5 | 30 | ||||||
| Cavstat | AF | MP | C1540 C3047 C4225 C4228 | P1540 P4228 | 30 | 5 | 30 | |||
| NP | C1540 C4228 | 30 | 5 | 30 | ||||||
| Chem mart Rosuvastatin | CH | MP | C4225 C4228 | P4228 | 30 | 5 | 30 | |||
| NP | C4228 | 30 | 5 | 30 | ||||||
| Crestor | AP | MP | C1540 C3047 C4225 C4228 | P1540 P4228 | 30 | 5 | 30 | |||
| NP | C1540 C4228 | 30 | 5 | 30 | ||||||
| Rosuvastatin Actavis 10 | WQ | MP | C1540 C3047 C4225 C4228 | P1540 P4228 | 30 | 5 | 30 | |||
| NP | C1540 C4228 | 30 | 5 | 30 | ||||||
| Rosuvastatin GH | GQ | MP | C1540 C3047 C4225 C4228 | P1540 P4228 | 30 | 5 | 30 | |||
| NP | C1540 C4228 | 30 | 5 | 30 | ||||||
| Rosuvastatin RBX | RA | MP | C4225 C4228 | P4228 | 30 | 5 | 30 | |||
| NP | C4228 | 30 | 5 | 30 | ||||||
| Rosuvastatin Sandoz | SZ | MP | C4225 C4228 | P4228 | 30 | 5 | 30 | |||
| NP | C4228 | 30 | 5 | 30 | ||||||
| Terry White Chemists Rosuvastatin | TW | MP | C4225 C4228 | P4228 | 30 | 5 | 30 | |||
| NP | C4228 | 30 | 5 | 30 | ||||||
| APO-Rosuvastatin | TX | MP | C4225 C4228 | P4225 | 30 | 11 | 30 | |||
| Cavstat | AF | MP | C1540 C3047 C4225 C4228 | P3047 P4225 | 30 | 11 | 30 | |||
| Chem mart Rosuvastatin | CH | MP | C4225 C4228 | P4225 | 30 | 11 | 30 | |||
| Crestor | AP | MP | C1540 C3047 C4225 C4228 | P3047 P4225 | 30 | 11 | 30 | |||
| Rosuvastatin Actavis 10 | WQ | MP | C1540 C3047 C4225 C4228 | P3047 P4225 | 30 | 11 | 30 | |||
| Rosuvastatin GH | GQ | MP | C1540 C3047 C4225 C4228 | P3047 P4225 | 30 | 11 | 30 | |||
| Rosuvastatin RBX | RA | MP | C4225 C4228 | P4225 | 30 | 11 | 30 | |||
| Rosuvastatin Sandoz | SZ | MP | C4225 C4228 | P4225 | 30 | 11 | 30 | |||
| Terry White Chemists Rosuvastatin | TW | MP | C4225 C4228 | P4225 | 30 | 11 | 30 | |||
| Tablet 20 mg (as calcium) | Oral | APO-Rosuvastatin | TX | MP | C4225 C4227 | P4227 | 30 | 5 | 30 | |
| NP | C4227 | 30 | 5 | 30 | ||||||
| Cavstat | AF | MP | C1540 C3047 C4225 C4227 | P1540 P4227 | 30 | 5 | 30 | |||
| NP | C1540 C4227 | 30 | 5 | 30 | ||||||
| Chem mart Rosuvastatin | CH | MP | C4225 C4227 | P4227 | 30 | 5 | 30 | |||
| NP | C4227 | 30 | 5 | 30 | ||||||
| Crestor | AP | MP | C1540 C3047 C4225 C4227 | P1540 P4227 | 30 | 5 | 30 | |||
| NP | C1540 C4227 | 30 | 5 | 30 | ||||||
| Rosuvastatin Actavis 20 | WQ | MP | C1540 C3047 C4225 C4227 | P1540 P4227 | 30 | 5 | 30 | |||
| NP | C1540 C4227 | 30 | 5 | 30 | ||||||
| Rosuvastatin GH | GQ | MP | C1540 C3047 C4225 C4227 | P1540 P4227 | 30 | 5 | 30 | |||
| NP | C1540 C4227 | 30 | 5 | 30 | ||||||
| Rosuvastatin RBX | RA | MP | C4225 C4227 | P4227 | 30 | 5 | 30 | |||
| NP | C4227 | 30 | 5 | 30 | ||||||
| Rosuvastatin Sandoz | SZ | MP | C4225 C4227 | P4227 | 30 | 5 | 30 | |||
| NP | C4227 | 30 | 5 | 30 | ||||||
| Terry White Chemists Rosuvastatin | TW | MP | C4225 C4227 | P4227 | 30 | 5 | 30 | |||
| NP | C4227 | 30 | 5 | 30 | ||||||
| APO-Rosuvastatin | TX | MP | C4225 C4227 | P4225 | 30 | 11 | 30 | |||
| Cavstat | AF | MP | C1540 C3047 C4225 C4227 | P3047 P4225 | 30 | 11 | 30 | |||
| Chem mart Rosuvastatin | CH | MP | C4225 C4227 | P4225 | 30 | 11 | 30 | |||
| Crestor | AP | MP | C1540 C3047 C4225 C4227 | P3047 P4225 | 30 | 11 | 30 | |||
| Rosuvastatin Actavis 20 | WQ | MP | C1540 C3047 C4225 C4227 | P3047 P4225 | 30 | 11 | 30 | |||
| Rosuvastatin GH | GQ | MP | C1540 C3047 C4225 C4227 | P3047 P4225 | 30 | 11 | 30 | |||
| Rosuvastatin RBX | RA | MP | C4225 C4227 | P4225 | 30 | 11 | 30 | |||
| Rosuvastatin Sandoz | SZ | MP | C4225 C4227 | P4225 | 30 | 11 | 30 | |||
| Terry White Chemists Rosuvastatin | TW | MP | C4225 C4227 | P4225 | 30 | 11 | 30 | |||
| Tablet 40 mg (as calcium) | Oral | APO-Rosuvastatin | TX | MP | C4225 C4226 | P4226 | 30 | 5 | 30 | |
| NP | C4226 | 30 | 5 | 30 | ||||||
| Cavstat | AF | MP | C1540 C3047 C4225 C4226 | P1540 P4226 | 30 | 5 | 30 | |||
| NP | C1540 C4226 | 30 | 5 | 30 | ||||||
| Chem mart Rosuvastatin | CH | MP | C4225 C4226 | P4226 | 30 | 5 | 30 | |||
| NP | C4226 | 30 | 5 | 30 | ||||||
| Crestor | AP | MP | C1540 C3047 C4225 C4226 | P1540 P4226 | 30 | 5 | 30 | |||
| NP | C1540 C4226 | 30 | 5 | 30 | ||||||
| Rosuvastatin Actavis 40 | WQ | MP | C1540 C3047 C4225 C4226 | P1540 P4226 | 30 | 5 | 30 | |||
| NP | C1540 C4226 | 30 | 5 | 30 | ||||||
| Rosuvastatin GH | GQ | MP | C1540 C3047 C4225 C4226 | P1540 P4226 | 30 | 5 | 30 | |||
| NP | C1540 C4226 | 30 | 5 | 30 | ||||||
| Rosuvastatin RBX | RA | MP | C4225 C4226 | P4226 | 30 | 5 | 30 | |||
| NP | C4226 | 30 | 5 | 30 | ||||||
| Rosuvastatin Sandoz | SZ | MP | C4225 C4226 | P4226 | 30 | 5 | 30 | |||
| NP | C4226 | 30 | 5 | 30 | ||||||
| Terry White Chemists Rosuvastatin | TW | MP | C4225 C4226 | P4226 | 30 | 5 | 30 | |||
| NP | C4226 | 30 | 5 | 30 | ||||||
| APO-Rosuvastatin | TX | MP | C4225 C4226 | P4225 | 30 | 11 | 30 | |||
| Cavstat | AF | MP | C1540 C3047 C4225 C4226 | P3047 P4225 | 30 | 11 | 30 | |||
| Chem mart Rosuvastatin | CH | MP | C4225 C4226 | P4225 | 30 | 11 | 30 | |||
| Crestor | AP | MP | C1540 C3047 C4225 C4226 | P3047 P4225 | 30 | 11 | 30 | |||
| Rosuvastatin Actavis 40 | WQ | MP | C1540 C3047 C4225 C4226 | P3047 P4225 | 30 | 11 | 30 | |||
| Rosuvastatin GH | GQ | MP | C1540 C3047 C4225 C4226 | P3047 P4225 | 30 | 11 | 30 | |||
| Rosuvastatin RBX | RA | MP | C4225 C4226 | P4225 | 30 | 11 | 30 | |||
| Rosuvastatin Sandoz | SZ | MP | C4225 C4226 | P4225 | 30 | 11 | 30 | |||
| Terry White Chemists Rosuvastatin | TW | MP | C4225 C4226 | P4225 | 30 | 11 | 30 |
Schedule 1, entry for Temozolomide in the form Capsule 180 mg
insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:
| Astromide | WQ | MP | C1736 C1737 C2101 | 5 | 5 | 5 |
Schedule 3, after details relevant to Responsible person code YT
insert:
| ZA | AstraZeneca Pty Ltd | 54 009 682 311 |
Schedule 4, Part 1, entry for Rosuvastatin
(a)insert in the column headed “Purposes Code” for the Circumstances Code “C1540” P1540
(b)insert in the column headed “Purposes Code” for the Circumstances Code “C3047” P3047
(c)insert in numerical order following existing text:
| C4225 | P4225 | For use in patients who meet the criteria set out in the General Statement for Lipid-Lowering Drugs Patient must be receiving treatment under a GP Management Plan or Team Care Arrangements where Medicare benefits were or are payable for the preparation of the Plan or coordination of the Arrangements; |
| C4226 | P4226 | For use in patients who meet the criteria set out in the General Statement for Lipid-Lowering Drugs The treatment must not be prescribed for hypercholesterolaemia if the patient has heterozygous familial hypercholesterolaemia |
| C4227 | P4227 | For use in patients who meet the criteria set out in the General Statement for Lipid-Lowering Drugs The treatment must not be prescribed for hypercholesterolaemia if the patient has heterozygous familial hypercholesterolaemia |
| C4228 | P4228 | For use in patients who meet the criteria set out in the General Statement for Lipid-Lowering Drugs The treatment must not be prescribed for hypercholesterolaemia if the patient has heterozygous familial hypercholesterolaemia |
1Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.
See
0
0
0